Susanne Heinzel

Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant.

Nikolai Petrovsky, Manon M J Cox, N. Petrovsky, 2012, Vaccine.

Immune activation in patients with irritable bowel syndrome.

Gerald Holtmann, N. Talley, S. Heinzel, 2007, Gastroenterology.

Antigen affinity, costimulation, and cytokine inputs sum linearly to amplify T cell expansion

Philip D. Hodgkin, Mark R. Dowling, Andrey Kan, 2014, Science.

Tumour-specific MHC-class-II-restricted responses after in vitro sensitization to synthetic peptides corresponding to gp100 and Annexin II eluted from melanoma cells

Thomas Halder, G. Pawelec, S. Heinzel, 1998, Cancer Immunology, Immunotherapy.

A Myc-dependent division timer complements a cell-death timer to regulate T cell and B cell responses

Andrey Kan, P. Hodgkin, S. Heinzel, 2016, Nature Immunology.

Stretched cell cycle model for proliferating lymphocytes

Jie H. S. Zhou, John F Markham, Andrey Kan, 2014, Proceedings of the National Academy of Sciences.

Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: a randomized controlled Phase 1 study.

Nikolai Petrovsky, N. Petrovsky, S. Heinzel, 2014, Vaccine.